'My number one idea is accumulating the ultra-high quality CSL' shares

Bell Potter says enough is enough, it's time to buy this giant's shares.

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recent months have not been kind to CSL Limited (ASX: CSL) shares.

The biotherapeutics giant's shares have fallen heavily since June and one leading broker believes that they could have finally bottomed.

In fact, Charlie Aitken from Bell Potter thinks "the falling knife is sticking in the valuation floor and it's time to pick it up."

Why now is the time to buy CSL shares

According to a note out of the broker, Aitken highlights that CSL shares are trading on their "lowest relative PE premium to the market since 2017."

In light of this, the analyst feels it is "time to start nibbling in CSL which remains Australia's highest quality global industrial business." Especially with its chair, Dr Brian McNamee, recently reiterating that its intention is to be and remain a growth company for a long time to come.

It is because of this, that Aitken has named the company as his top pick for the month. He said:

My number one idea is accumulating the ultra-high quality CSL. […] McNamee's comments, combined with the reiteration of guidance last week, and arguably peak hysteria on weight loss drugs and some questioning articles in the financial press about CSL's future, all combine with the lowest relative valuation in 6 years to get my attention. I think it's time to start accumulating CSL.

The team at Citi agrees. It has a buy rating and a $325 price target on CSL's shares, which implies a potential upside of approximately 30%.

It recently highlighted that "CSL is trading on a PE FY25 of ~22x, a 6x discount to historical average." The broker also believes that "CSL is winning share [in the United States flu vaccine market] despite the lower vaccination rate."

Overall, quality of this standard doesn't go on sale very often and these brokers are urging investors to take advantage.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Guess which ASX 300 stock is jumping 11% on big news

This stock is having a day to remember on Thursday. But why?

Read more »

A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Trump executive order to hit these 3 ASX pharmaceutical stocks

Donald Trump’s new executive order caused these 3 ASX pharmaceutical stocks to crash on Monday.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Healthcare Shares

Guess which ASX 200 stock is jumping 16% on big news

Let's find out what news is getting investors excited this afternoon.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Healthcare Shares

Why is this ASX 300 stock crashing 18% today?

Investors are rushing to the exits. But why? Let's look into things.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are CSL shares at risk from the Trump tariffs?

How exposed are CSL shares to potential Trump medicinal tariffs?

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

What did CSL have to say at Macquarie's 2025 conference?

Does this business have a healthy growth outlook?

Read more »

smiling health care workers in a medical setting
Healthcare Shares

Sonic Healthcare shares are down more than 40% since 2021. Will its AI initiative be the catalyst for a turnaround?

Could AI spark a recovery for this ASX healthcare stock?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Why is this ASX All Ords stock jumping 7% today?

This stock is ending the week strongly. Let's find out what is getting investors excited.

Read more »